As of August 28, 2026, Catalyst Pharmaceuticals, Inc. (CPRX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Catalyst Pharmaceuticals, Inc. has a market capitalization of $3.82B, 122.38M shares outstanding, 385 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CPRX.
Market Data
Market Cap$3.82B
Shares Outstanding122.38M
Float115.58M
Cash$755.86M
Debt$2.68M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 12.3% shares (2026Q1 vs prior)
385 institutional holders · 121.60M shares
#1
BlackRock, Inc.
18.77M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
10.25M shares
#3
MORGAN STANLEY
7.46M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest340.3K
Days to Cover1.0
% of Float0.3%
FINRA data as of Jul 15, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2017-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CPRX Dilution Snapshot
Catalyst Pharmaceuticals, Inc. (CPRX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CPRX: xbrl on 2017-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CPRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CPRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CPRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.